Cardioprotective-Mimetics Reduce Myocardial Infarct Size in Animals Resistant to Ischemic Preconditioning

By Gumina Richard   Schultz Jo El   Moore Jeanine   Beier Norbert   Schelling Pierre   Gross Garrett  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 315-322

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion

By Alberola Aguilar A.M.   Revert F.   Moya A.   Beltran J.   Garca J.   San Martn E.   Sancho S.   Such L.  

General Pharmacology, Vol. 35, Iss. 3, 2000-09 ,pp. : 143-147

Elsevier

Access to resources Recommend Favorite

Multiscale Characterization of Impact of Infarct Size on Myocardial Remodeling in an Ovine Infarct Model

By  

Cells Tissues Organs, Vol. 200, Iss. 5, 2015-0 ,pp. : 349-362

Karger

Access to resources Recommend Favorite

ITF 1697: potential to reduce infarct size?

By  

Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

By Lexis Chris   Wieringa Wouter   Hiemstra Bart   Deursen Vincent   Lipsic Erik   Harst Pim   Veldhuisen Dirk   Horst Iwan  

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite